Literature DB >> 23266472

Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility.

Mizue Fujii1, Masaru Honma, Hidetoshi Takahashi, Akemi Ishida-Yamamoto, Hajime Iizuka.   

Abstract

The transmembrane glycoprotein podoplanin (PDPN) plays an important role in cell motility. However, mechanisms regulating PDPN expression have not been fully elucidated. Here, we investigated the effect of intercellular contact on signal transduction pathways and PDPN expression in human squamous cell carcinoma (SCC) cell lines. PDPN expression was higher in confluent SCC cells than sparse cultures. This PDPN induction leads to increased SCC cell migration and invasion, which was reversed by shRNA PDPN knockdown. This cell density dependent PDPN induction required activation of epidermal growth factor receptor (EGFR) and its effector, signal transducer and activator of transcription 3 (STAT3). These observations also extend to human clinical specimens, in which PDPN expression localized to confluent basal cell layers at the invading front of in situ SCC lesions. Taken together, these results illuminate an EGFR-STAT3-PDPN pathway as a potential pharmacological opportunity to target invasive SCC cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266472     DOI: 10.1016/j.cellsig.2012.12.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility.

Authors:  Harini Krishnan; Edward P Retzbach; Maria I Ramirez; Tong Liu; Hong Li; W Todd Miller; Gary S Goldberg
Journal:  Exp Cell Res       Date:  2015-05-07       Impact factor: 3.905

2.  Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration.

Authors:  Edward P Retzbach; Stephanie A Sheehan; Harini Krishnan; Haiyan Zheng; Caifeng Zhao; Gary S Goldberg
Journal:  Mol Carcinog       Date:  2022-04-26       Impact factor: 5.139

3.  High EGFR_1 Inside-Out Activated Inflammation-Induced Motility through SLC2A1-CCNB2-HMMR-KIF11-NUSAP1-PRC1-UBE2C.

Authors:  Huilei Zhou; Lin Wang; Juxiang Huang; Minghu Jiang; Xiaoyu Zhang; Liyuan Zhang; Yangming Wang; Zhenfu Jiang; Zhongjie Zhang
Journal:  J Cancer       Date:  2015-04-05       Impact factor: 4.207

4.  Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Authors:  Jhon A Ochoa-Alvarez; Harini Krishnan; John G Pastorino; Evan Nevel; David Kephart; Joseph J Lee; Edward P Retzbach; Yongquan Shen; Mahnaz Fatahzadeh; Soly Baredes; Evelyne Kalyoussef; Masaru Honma; Martin E Adelson; Mika K Kaneko; Yukinari Kato; Mary Ann Young; Lisa Deluca-Rapone; Alan J Shienbaum; Kingsley Yin; Lasse D Jensen; Gary S Goldberg
Journal:  Oncotarget       Date:  2015-04-20

5.  Erythropoietin Modification Enhances the Protection of Mesenchymal Stem Cells on Diabetic Rat-Derived Schwann Cells: Implications for Diabetic Neuropathy.

Authors:  Shuyun Zhang; Baolin Shi
Journal:  Biomed Res Int       Date:  2017-02-19       Impact factor: 3.411

6.  Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells.

Authors:  Stephanie A Sheehan; Edward P Retzbach; Yongquan Shen; Harini Krishnan; Gary S Goldberg
Journal:  Cell Commun Signal       Date:  2022-02-17       Impact factor: 5.712

7.  Critical analysis of the potential for targeting STAT3 in human malignancy.

Authors:  Noah D Peyser; Jennifer R Grandis
Journal:  Onco Targets Ther       Date:  2013-07-30       Impact factor: 4.147

8.  DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells.

Authors:  Jelena Ivanovska; Inti Zlobec; Stefan Forster; Eva Karamitopoulou; Heather Dawson; Viktor Hendrik Koelzer; Abbas Agaimy; Fabian Garreis; Stephan Söder; William Laqua; Alessandro Lugli; Arndt Hartmann; Tilman T Rau; Regine Schneider-Stock
Journal:  Oncotarget       Date:  2015-11-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.